LabReflex
Making diagnostics clearer, smarter, and more effective. Bringing the story behind the numbers.
Latest Episodes
Lab Inspection Debrief: Staff Interviews and Lab Coordination
March 16, 2026
Laboratory inspections are not just about documentation and policies. They are also about the people who make the laboratory function every day. In this episode of LabReflex, Dr. Christopher Zahner and Dr. Aakash continue their inspection debrief series by discussing two important parts of the inspection process: staff interviews and inspection coordination. Inspectors spend a significant amount of time talking with technologists, supervisors, and laboratory leaders. These conversations help inspectors understand how procedures are actually carried out and how well the team understands the work they do. Chris and Aakash explain how inspectors approach these discussions and why interviews are meant to understand the laboratory rather than catch staff off guard. The conversation also explores the logistics behind a smooth inspection. Good coordination makes a huge difference. When laboratories organize document requests, assign escorts, and maintain clear communication, the entire process becomes far less stressful for both the inspection team and the laboratory staff. This episode highlights how preparation, teamwork, and transparency can turn an inspection into a constructive experience for everyone involved. In this episode you will hear What inspectors are really looking for when they talk with laboratory staff How laboratories can prepare employees for interviews without over rehearsing Why honest and thoughtful answers matter more than perfect ones The role of laboratory leadership during the inspection How strong coordination keeps the inspection organized and efficient Key takeaway A successful inspection depends on more than policies and documentation. It depends on knowledgeable staff, open communication, and a laboratory team that works together throughout the process.
Listen Now →
Lab Inspection Debrief: The Opening Meeting and the Lab Tour
March 9, 2026
What really happens in the first moments of a laboratory inspection? In this episode of LabReflex, Dr. Christopher Zahner and Dr. Aakash walk through the very beginning of the inspection process, focusing on the opening meeting and the laboratory tour. These first interactions often shape the tone of the entire visit. Before any records are reviewed or deficiencies are discussed, inspectors are forming impressions about the laboratory, the team, and how the lab operates. Chris and Aakash talk through what inspectors are hoping to accomplish during the opening conference, how laboratories can set themselves up for a smooth inspection, and why these early conversations are more important than many people realize. They also discuss the lab tour, which gives inspectors their first real look at workflow, organization, and the overall culture of the laboratory. Small details can reveal a lot, and the tour often helps inspectors understand how policies and procedures translate into everyday practice. This episode is a behind the scenes look at how inspections begin and what laboratories can do to make those first moments productive and collaborative. In this episode you will hear: What inspectors are hoping to learn during the opening meeting How introductions and tone can influence the entire inspection Why the laboratory tour provides valuable insight into daily operations Common early inspection mistakes laboratories sometimes make Simple ways labs can start the inspection process with confidence Key takeaway: The opening meeting and the lab tour are not just formalities. They are an opportunity to establish trust, set expectations, and begin the inspection as a professional collaboration.
Listen Now →
Tariffs rejected
March 2, 2026
LabReflex Three Forces Shaping the Lab This Week: Tariffs, Digital Pathology, and Genome First Care This week’s episode connects three very different headlines that all land directly inside the clinical laboratory. We discuss a Supreme Court ruling on tariffs, a major digital pathology deployment, and a new clinical whole genome sequencing initiative for pediatric rare disease. On the surface, these topics seem unrelated. In practice, they all affect how laboratories operate, spend, and plan for the future. We begin with the recent Supreme Court decision striking down certain Trump era tariffs that had been implemented under the International Emergency Economic Powers Act. US Customs has stopped collecting the affected tariffs, but the situation around refunds remains uncertain. While trade law may feel distant from everyday lab operations, tariffs directly influence the cost of analyzers, reagents, consumables, and replacement parts. Many laboratory supplies rely on imported components. Even modest trade shifts can create pricing volatility, contract changes, and supply chain disruptions. We discuss what lab leaders should be watching in vendor agreements and procurement planning. Next, we turn to digital pathology. Labcorp announced an expanded collaboration with PathAI to deploy its FDA cleared digital pathology platform across its anatomic pathology network. This signals that digital pathology is no longer experimental. It is infrastructure. We talk through what this really means operationally, including scanner throughput, storage demands, validation studies, display calibration, IT integration, and ongoing quality oversight. Digital pathology is not simply about scanning slides. It represents a workflow transformation. We also discuss how artificial intelligence tools fit into this landscape and the difference between decision support and automation. Finally, we examine a new clinical whole genome sequencing initiative in Florida focused on pediatric rare disease. Illumina announced it will provide clinical sequencing and interpretation services to support this program. This reflects a shift toward genome first diagnostic strategies aimed at shortening the diagnostic odyssey for children with complex or undiagnosed conditions. We explore the laboratory implications, including variant interpretation, management of variants of uncertain significance, reanalysis policies, and coordination with clinical teams. Even laboratories that do not perform sequencing in house may feel the impact through changing send out patterns and evolving clinician expectations. Taken together, these three stories illustrate the pressures shaping modern laboratory medicine. Policy decisions influence cost. Technology reshapes workflow. Genomics alters the test menu and diagnostic strategy. The laboratory is no longer insulated from these broader forces. It sits at the center of them. If one of these developments is affecting your laboratory, whether through rising costs, digital implementation challenges, or expanding genomics demands, we welcome your perspective and feedback for future episodes.
Listen Now →About LabReflex
Diagnostics sit underneath almost every decision in medicine, but most people only see the numbers and not the story behind them. LabReflex brings that story forward, giving it context, and helping people understand what matters and what does not.
Direct, practical, and grounded in actual work rather than theory. Join Dr. Christopher Zahner, a clinical pathologist and former NASA engineer, as he explores the intersection of precision, systems thinking, and diagnostic medicine.
Meet the Creator